Navigation Links
CeNeRx BioPharma Initiates Phase II Clinical Trial of Its Novel Antidepressant Agent Tyrima(TM)
Date:10/17/2008

rrently prescribed antidepressant drugs."

CeNeRx has worldwide rights to develop and commercialize Tyrima. This compound, which could be the first RIMA antidepressant available in the U.S. market, has patent protection beyond 2027.

About CeNeRx BioPharma

CeNeRx is a privately held clinical stage biopharmaceutical company developing and commercializing innovative treatments for diseases of the central nervous system. CeNeRx's most advanced compound, a reversible inhibitor of monoamine oxidase, or RIMA, has entered Phase II development for the treatment of major depressive disorder. RIMAs may have efficacy advantages over current agents for depression and are expected to have a good safety profile. The company is also developing its pipeline of selective cannabinoid compounds that have recently completed successful preclinical proof-of-concept studies for the treatment of pain, glaucoma and spasticity. More information about CeNeRx BioPharma can be found at http://www.cenerx.com.

Contact:

GendeLLindheim BioCom Partners

Barbara Lindheim

212 918 4650


'/>"/>
SOURCE CeNeRx BioPharma, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. CeNeRx BioPharma Finalizes Plans to Initiate Phase II Trials for Its Novel Antidepressant Agent Tyrima(TM) Using Innovative Brain Imaging Study
2. CeNeRx BioPharma Announces Successful Completion of Phase l Clinical Program for Novel Antidepressant Agent Tyrima(TM)
3. InCode BioPharmaceutics, Inc. Announces Key Data Supporting New Treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH)
4. XTL Biopharmaceuticals Announces Completion of Patient Randomization Into the Bicifadine Phase 2b Clinical Trial for the Treatment of Diabetic Neuropathic Pain
5. Morria Biopharmaceuticals Plc Announces the Initiation of a Phase II Clinical Multi-dose Study of MRX-4 in Allergic Rhinitis
6. CB1400, Patented by Canopus BioPharma, Enters Phase II Clinical Trials for the Prevention of Mucositis in Patients With Cancer of the Head and Neck
7. Canopus BioPharma Strengthens its CB1400 Platform Technology for Mucositis and Oncology Treatments Through License Agreement With Wisconsin Alumni Research Foundation
8. Morria Biopharmaceuticals Plc Announces Regulatory Approval to Commence Phase II Clinical Study of MRX-4 in Allergic Rhinitis
9. Keryx Biopharmaceuticals, Inc. Announces Phase 2 Results on KRX-0401 (Perifosine) in Patients with Relapsed/Refractory Waldenstroms Macroglobulinemia at the 44th Annual Meeting of the American Society of Clinical Oncology
10. Keryx Biopharmaceuticals, Inc. Announces Poster Presentation Highlighting Observed Clinical Activity of KRX-0401 (Perifosine) at the American Society of Clinical Oncology Meeting in Chicago, Illinois
11. Keryx Biopharmaceuticals Announces Termination of SUN-MACRO Phase 4 Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2015)... Biosimilars are not generics and the ... and Drug Administration (FDA) for recognizing that each ... guidance issued today. The FDA,s draft guidance on ... calling for biological products to bear a nonproprietary ... reflects the agency,s thinking that "there is a ...
(Date:8/27/2015)... 27, 2015 According to a new market ... Seating, Universal, Standing, Bariatric ), Material (Nylon, Padded, Canvas), Usage Type ... published by MarketsandMarkets, the Medical Lifting Sling Market is poised to ... 2015, at a CAGR of 11.4 % from 2015 to 2020. ... rket data T ables and 65 ...
(Date:8/27/2015)... 27, 2015  Now that Intuitive Surgical, Inc.® has ... surgical robot, hospitals with robotic surgery programs need to ... to see where they stand with robotic surgery. Are ... Have they adopted best practices for safety? Should they ... future? ECRI Institute, which has nearly 50 ...
Breaking Medicine Technology:Biologics Prescribers Collaborative (BPC) Statement on FDA Draft Guidance entitled "Nonproprietary Naming of Biological Products" 2Medical Lifting Sling Market Worth USD 706.0 Million by 2020 2Medical Lifting Sling Market Worth USD 706.0 Million by 2020 3Medical Lifting Sling Market Worth USD 706.0 Million by 2020 4ECRI Institute's New Robotic Surgery Service Helps Hospitals Brace for Change 2ECRI Institute's New Robotic Surgery Service Helps Hospitals Brace for Change 3
... advantage of five major benefits of the new health care law, ... To help you better understand the Affordable Care Act, ... , a web portal that explains what,s changing and when. ... is Mayra Alvarez, Director of Public Health Policy in the Office ...
... 2011 Echo Therapeutics, Inc. (OTCBB: ... as a non-invasive, wireless, transdermal continuous glucose monitoring ... transdermal drug delivery, today announced that Christopher P. ... Financial Officer.  Mr. Schnittker is a senior executive ...
Cached Medicine Technology:Five Benefits of the New Health Care Law 2Echo Therapeutics Appoints Christopher P. Schnittker as Chief Financial Officer 2Echo Therapeutics Appoints Christopher P. Schnittker as Chief Financial Officer 3
(Date:8/28/2015)... ... August 28, 2015 , ... ... loyalty at a low cost. Personalized with practice contact information and logos, Calendars ... Dental offices can also incorporate Calendars into seasonal mailings, thank you and welcome ...
(Date:8/28/2015)... ... 2015 , ... SharkNinja, an innovative leader in the housewares ... Sofia Vergara, and unveil the Ninja® brand’s new coffee machine, the Ninja ... variety of sizes and styles while achieving the perfect brew richness level every ...
(Date:8/28/2015)... ... August 28, 2015 , ... ... added comprehensive information on two new duals programs: Rhode Island Integrated Care ... and Idaho’s partnership to revamp Blue Cross of Idaho’s D-SNP. The database ...
(Date:8/28/2015)... ... August 28, 2015 , ... The Plaintiffs ... as MDL 2545, Testosterone Replacement Therapy Products Liability Litigation, are in the midst ... custodial files the PSC may receive for corporate employees involved in the production ...
(Date:8/28/2015)... ... August 28, 2015 , ... Super-Sod launched their new website this ... most notable change is the responsive web design. Website users will now have an ... submit quote requests for sod, sign-up for the monthly turf-tips email, and find a ...
Breaking Medicine News(10 mins):Health News:SmartPractice® Introduces 2016 Calendars for Dental Practice Giveaways 2Health News:Sofia Vergara Partners With SharkNinja® To Launch The Ninja Coffee Bar™ 2Health News:Sofia Vergara Partners With SharkNinja® To Launch The Ninja Coffee Bar™ 3Health News:AIS Duals Database: August Update Finds Two New Duals Programs in Rhode Island and Idaho 2Health News:National Testosterone Lawyers Provide Testosterone Lawsuit MDL Update 2Health News:National Testosterone Lawyers Provide Testosterone Lawsuit MDL Update 3Health News:National Testosterone Lawyers Provide Testosterone Lawsuit MDL Update 4
... treatment for Peripheral Artery DiseaseAUSTIN, Texas, Jan. 8 ... is the first hospital in the world to ... to successfully treat chronic total occlusions (CTOs), or ... Heart interventional cardiologist, Frank Zidar, M.D. used the ...
... MEMPHIS, Tenn., Jan. 8 St. Jude Children,s Research,Hospital(R) ... has increased his commitment to Eagles for St. Jude ... St. Jude for every eagle he,cards on the 2009 ... powerful program that,has united Villegas, FedExCup Champion Vijay Singh ...
... to Terrorist Missile StrikesNEW YORK, Jan. 8 ... North America today committed to raise $10 million to ... of a major initiative to support and stand in ... the terrorist organization in control of the Gaza Strip. ...
... Jan. 8 The National eHealth Collaborative, formerly AHIC ... leadership elections in which Kevin Hutchinson, President and CEO ... Chair of the organization,s 2009 Board of Directors. ... Health Information Community (AHIC), a federal advisory committee established ...
... Wyeth (NYSE: WYE ) announced today that ... on Wednesday, January 14, 2009 at 11:30 a.m. Eastern ... President, U.S. and Pharmaceutical Business Units, Wyeth Pharmaceuticals. Wyeth,s ... www.wyeth.com and available for replay following the conference.Wyeth ...
... ColiseumNEW YORK, Jan. 8 Stand Up for a Cure ... a Valentine,s Day show with Barry Manilow , in partnership ... held on February 14th, 2009 at Nassau Coliseum, and tickets for ... or by calling Stand Up for a Cure at 212 209 ...
Cached Medicine News:Health News:Heart Hospital of Austin First in World to Use New Device for Blocked Arteries 2Health News:Not to be Outdone by FedExCup Champion Vijay Singh, FedExCup Runner-Up Camilo Villegas Increases Commitment to Children of St. Jude 2Health News:Not to be Outdone by FedExCup Champion Vijay Singh, FedExCup Runner-Up Camilo Villegas Increases Commitment to Children of St. Jude 3Health News:Not to be Outdone by FedExCup Champion Vijay Singh, FedExCup Runner-Up Camilo Villegas Increases Commitment to Children of St. Jude 4Health News:UJC and Jewish Federations of North America Commit $10 Million for Needs in Southern Israel 2Health News:Kevin Hutchinson Elected Vice Chair of Board of Directors for National eHealth Collaborative 2Health News:Wyeth to Present at the JP Morgan Healthcare Conference 2Health News:Barry Manilow Brings Valentine's and Music to New York With Concert to Raise Funds for Breast Cancer Research 2
... The introduction of the AMO ... in Phaco technology; The combination of ... in complete control of fluidic conditions ... as the "smart Pump" orchestrates the ...
... The Catalyst system introduces a ... precision to microsurgical instrumentation. It ... digital design with advanced microcomputer ... simple to operate with a ...
The CV-12000 provides the surgeon with all the options to perform today's newest techniques....
Compact ultrasonic phacoemulsification system....
Medicine Products: